Does BEXAROTENE Cause Hepatic function abnormal? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hepatic function abnormal have been filed in association with BEXAROTENE (Bexarotene). This represents 0.9% of all adverse event reports for BEXAROTENE.
7
Reports of Hepatic function abnormal with BEXAROTENE
0.9%
of all BEXAROTENE reports
1
Deaths
2
Hospitalizations
How Dangerous Is Hepatic function abnormal From BEXAROTENE?
Of the 7 reports, 1 (14.3%) resulted in death, 2 (28.6%) required hospitalization.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEXAROTENE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does BEXAROTENE Cause?
Drug ineffective (67)
Hypothyroidism (65)
Death (53)
Hypertriglyceridaemia (44)
Off label use (32)
Disease progression (28)
Blood cholesterol increased (27)
Malignant neoplasm progression (26)
Pruritus (24)
Nausea (22)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which BEXAROTENE Alternatives Have Lower Hepatic function abnormal Risk?
BEXAROTENE vs BEZAFIBRATE
BEXAROTENE vs BEZLOTOXUMAB
BEXAROTENE vs BGB-11417
BEXAROTENE vs BICALUTAMIDE
BEXAROTENE vs BICTEGRAVIR